Skip to main content

Table 2 Defined test conditions for each test gas exchanger

From: In vitro characterization of PrismaLung+: a novel ECCO2R device

A. Test media bovine blood

 

From abattoir, stored at 4 °C

• Anticoagulation: Heparin (~ 5 U/mL)

• Filtered (50 μm, polyamine, SEFAR-NITEX)

• Total Proteins: 60 ± 5 g/L

• Hct: 31–33%

• Viscosity, blood plasma: 1.50–1.64 mm2/s

• c(Base)B: 0 ± 5 mmol/L

B. Set-up

Blood flow rates (QB)

200, 300, 450 mL/min ± 4.3%*

pinCO2_ref

45, 60, 80 mmHg ±10%

Sweep gas flow rates

10 ± 1 L/min

Temperature in blood reservoir

37 ± 1 °C

ctHb

12 ± 1 g/dL

c(Base) B

0 ± 5 mmol/L

Na+

Initial concentration ± 5 mmol/L

  1. A. Adjusted parameters of test media before experimentation. B. Set and controlled parameters during experimentation
  2. c(Base) B base excess in blood, ctHb total hemoglobin concentration, Hct hematocrit, Na+ sodium ion, pCO2 partial pressure of carbon dioxide, pinCO2_ref target inlet pCO2, QB blood flow rate
  3. *The PrismaLung+ and A.L.ONE devices were additionally tested at QB 600 mL/min and pinCO2 45 mmHg